Ownership history in STEMPOINT CAPITAL LP · 8 quarters on record
This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in KALVISTA PHARMACEUTICALS INC (KALV). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | REDUCED | 56,770 | -330,020 | -85.3% | 0.14% | $691K | $12.18 |
| 2025 Q2 | REDUCED | 386,790 | -47 | -0.0% | 1.40% | $4.4M | $11.31 |
| 2025 Q1 | ADDED | 386,837 | +286,837 | +286.8% | 1.42% | $4.5M | $11.54 |
| 2025 Q1 | REDUCED | 100,000 | -892,803 | -89.9% | 0.01% | $32K | $11.54 |
| 2024 Q4 | ADDED | 992,803 | +256,038 | +34.8% | 2.10% | $8.4M | $8.47 |
| 2024 Q2 | REDUCED | 736,765 | -424,295 | -36.5% | 2.55% | $8.7M | $11.78 |
| 2024 Q1 | ADDED | 1,161,060 | +737,886 | +174.4% | 3.64% | $13.8M | $11.86 |
| 2023 Q4 | INITIATED | 423,174 | — | — | 1.38% | $5.2M | — |
As of 2025 Q4 — sorted by position size